Management of Severe Malaria: Results from Recent Trials

Part of the Advances in Experimental Medicine and Biology book series (AEMB)

Abstract

Globally, malaria remains a substantial public health burden with an estimated 349–552 million clinical cases of P. falciparum malaria each year—leading to 780,000 deaths directly attributable to the disease. Whilst the outcome from severe malaria in Africa children remains poor, recent developments in the management of malaria have come from two key sources—the introduction of new, safe and rapidly-effective anti-malarials and high quality evidence from two of the largest clinical trials ever conducted in African children with severe malaria. As a result, the time-honoured anti-malarial treatment for severe malaria, quinine, will now be replaced by artesunate, a water-soluble artemisinin derivative. Supportive care, specifically the management of shock, has been informed by a large late phase clinical trial which concluded that bolus resuscitation is harmful and therefore should be avoided in children with severe malaria, including the high risk group with severe metabolic acidosis and advanced shock.

References

  1. 1.
    Anstey NM, Russell B, Yeo TW, Price RN (2009) The pathophysiology of vivax malaria. Trends Parasitol 25(5):220–227PubMedCrossRefGoogle Scholar
  2. 2.
    Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, Noor AM et al (2009) A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6(3):e1000048PubMedCrossRefGoogle Scholar
  3. 3.
    Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA et al (2010) Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med 7(6):e1000290PubMedCrossRefGoogle Scholar
  4. 4.
    Okiro EA, Alegana VA, Noor AM, Mutheu JJ, Juma E, Snow RW (2009) Malaria paediatric hospitalization between 1999 and 2008 across Kenya. BMC Med 7(1):75PubMedCrossRefGoogle Scholar
  5. 5.
    Okiro EA, Alegana VA, Noor AM, Snow RW (2010) Changing malaria intervention coverage, transmission and hospitalization in Kenya. Malar J 9:285PubMedCrossRefGoogle Scholar
  6. 6.
    Okiro EA, Bitira D, Mbabazi G, Mpimbaza A, Alegana VA, Talisuna AO et al (2011) Increasing malaria hospital admissions in Uganda between 1999 and 2009. BMC Med 9:37PubMedCrossRefGoogle Scholar
  7. 7.
    Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD et al (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376(9753):1647–1657PubMedCrossRefGoogle Scholar
  8. 8.
    Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO et al (2011) Mortality after fluid bolus in African children with severe infection. N Engl J Med 364(26):2483–2495PubMedCrossRefGoogle Scholar
  9. 9.
    Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K et al (1987) Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 81(3):478–486PubMedCrossRefGoogle Scholar
  10. 10.
    Newton CR, Krishna S (1998) Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 79(1):1–53PubMedCrossRefGoogle Scholar
  11. 11.
    English M, Waruiru C, Amukoye E, Murphy S, Crawley J, Mwangi I et al (1996) Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. Am J Trop Med Hyg 55(5):521–524PubMedGoogle Scholar
  12. 12.
    Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V et al (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332(21):1399–1404PubMedCrossRefGoogle Scholar
  13. 13.
    Maitland K (2006) Severe malaria: lessons learned from the management of critical illness in children. Trends Parasitol 22(10):457–462PubMedCrossRefGoogle Scholar
  14. 14.
    English M, Punt J, Mwangi I, McHugh K, Marsh K (1996) Clinical overlap between malaria and severe pneumonia in Africa children in hospital. Trans R Soc Trop Med Hyg 90(6):658–662PubMedCrossRefGoogle Scholar
  15. 15.
    von Seidlein L, Olaosebikan R, Hendriksen IC, Lee SJ, Adedoyin OT, Agbenyega T et al (2012) Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Infect Dis 54(8):1080–1090PubMedCrossRefGoogle Scholar
  16. 16.
    Maitland K, Nadel S, Pollard AJ, Williams TN, Newton CR, Levin M (2005) Management of severe malaria in children: proposed guidelines for the United Kingdom. BMJ 331(7512):337–343PubMedCrossRefGoogle Scholar
  17. 17.
    World Health Organization, Communicable Diseases Cluster (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94(Suppl 1):S1–90Google Scholar
  18. 18.
    Paediatric basic and advanced life support guidelines: An update. Paediatrics & child health. 2007; 12(6):495–500Google Scholar
  19. 19.
    Berkley J, Mwarumba S, Bramham K, Lowe B, Marsh K (1999) Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg 93(3):283–286PubMedCrossRefGoogle Scholar
  20. 20.
    Nadjm B, Amos B, Mtove G, Ostermann J, Chonya S, Wangai H et al (2010) WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study. BMJ 340:c1350PubMedCrossRefGoogle Scholar
  21. 21.
    Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R, Clementi M (2010) The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev 23(1):235–251PubMedCrossRefGoogle Scholar
  22. 22.
    Graham SM, Walsh AL, Molyneux EM, Phiri AJ, Molyneux ME (2000) Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans R Soc Trop Med Hyg 94(3):310–314PubMedCrossRefGoogle Scholar
  23. 23.
    Mtove G, Amos B, von Seidlein L, Hendriksen I, Mwambuli A, Kimera J et al (2010) Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies. PLoS One 5(2):e9244PubMedCrossRefGoogle Scholar
  24. 24.
    Dondorp A, Nosten F, Stepniewska K, Day N, White N (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366(9487):717–725PubMedCrossRefGoogle Scholar
  25. 25.
    Murphy SA, Mberu E, Muhia D, English M, Crawley J, Waruiru C et al (1997) The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg 91(3):331–334PubMedCrossRefGoogle Scholar
  26. 26.
    Hien T, Davis T, Chuong L, Ilett K, Sinh D, Phu N et al (2004) Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob agents chemother 48:4234–4239PubMedCrossRefGoogle Scholar
  27. 27.
    Brockman A, Price R, van Vugt M, Heppner D, Walsh D, Sooklo P et al (2000) Plasmodium falciparum antimalarial drug susceptibility on the northwestern border of Thailand during five years of extensive artesunate-mefloquine use. Trans R Soc Trop Med Hyg 94:537–544PubMedCrossRefGoogle Scholar
  28. 28.
    Nealon C, Dzeing A, Muller-Romer U, Planche T, Sinou V, Kombila M et al (2002) Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria. Antimicrob Agents Chemother 46(12):3933–3939PubMedCrossRefGoogle Scholar
  29. 29.
    World Health Organization (2005) Hospital care for children: guidelines for the management of common illnesses with limited resources. Geneva, Switzerland. Report No.: ISBN 92 4 154670 0Google Scholar
  30. 30.
    Planche T, Onanga M, Schwenk A, Dzeing A, Borrmann S, Faucher JF et al (2004) Assessment of volume depletion in children with malaria. Plos Med 1(1):e18PubMedCrossRefGoogle Scholar
  31. 31.
    Planche T (2006) Malaria and fluids—balancing acts. Trends Parasitol 21:562–567CrossRefGoogle Scholar
  32. 32.
    Crawley J, Chu C, Mtove G, Nosten F (2010) Malaria in children. Lancet 375(9724):1468–1481PubMedCrossRefGoogle Scholar
  33. 33.
    Maitland K, Levin M, English M, Mithwani S, Peshu N, Marsh K, Severe P et al (2003) Falciparum malaria in Kenyan children: evidence for hypovolaemia. QJM 96(6):427–434PubMedCrossRefGoogle Scholar
  34. 34.
    Maitland K, Pamba A, Newton CR, Levin M (2003) Response to volume resuscitation in children with severe malaria. Pediatr Crit Care Med 4(4):426–431PubMedCrossRefGoogle Scholar
  35. 35.
    Beare NA, Riva CE, Taylor TE, Molyneux ME, Kayira K, White VA et al (2006) Changes in optic nerve head blood flow in children with cerebral malaria and acute papilloedema. J Neurol Neurosurg Psychiatry 77(11):1288–1290PubMedCrossRefGoogle Scholar
  36. 36.
    English M (2000) Life-threatening severe malarial anaemia. Trans R Soc Trop Med Hyg 94(6):585–588PubMedCrossRefGoogle Scholar
  37. 37.
    Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O et al (2004) Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 329(7476):1212PubMedCrossRefGoogle Scholar
  38. 38.
    Evans JA, Adusei A, Timmann C, May J, Mack D, Agbenyega T et al (2004) High mortality of infant bacteraemia clinically indistinguishable from severe malaria. QJM 97(9):591–597PubMedCrossRefGoogle Scholar
  39. 39.
    Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JG, Fosiko NG et al (2004) Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 10(2):143–145PubMedCrossRefGoogle Scholar
  40. 40.
    Bronzan RN, Taylor TE, Mwenechanya J, Tembo M, Kayira K, Bwanaisa L et al (2007) Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis 195(6):895–904PubMedCrossRefGoogle Scholar
  41. 41.
    Maitland K, Pamba A, Newton CR, Levin M (2003) Response to volume resuscitation in children with severe malaria. Pediatr Crit Care Med 4(4):426–431PubMedCrossRefGoogle Scholar
  42. 42.
    Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton CRJC et al (2005) Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clin Infect Dis 40:538–545PubMedCrossRefGoogle Scholar
  43. 43.
    Akech S, Gwer S, Idro R, Fegan G, Eziefula AC, Newton CR et al (2006) Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. PLoS Clin Trials 1(5):e21PubMedCrossRefGoogle Scholar
  44. 44.
    Southall DP, Samuels MP (2011) Treating the wrong children with fluids will cause harm: response to ’mortality after fluid bolus in African children with severe infection’. Arch Dis Child 96(10):905–906PubMedCrossRefGoogle Scholar
  45. 45.
    Myburgh JA (2011) Fluid resuscitation in acute illness–time to reappraise the basics. N Engl J Med 364(26):2543–2544PubMedCrossRefGoogle Scholar
  46. 46.
    Hilton AK, Bellomo R (2011) Totem and taboo: fluids in sepsis. Critical Care 15(3):164PubMedCrossRefGoogle Scholar
  47. 47.
    Duke T (2011) What the African fluid-bolus trial means. Lancet 378(9804):1685–1687PubMedCrossRefGoogle Scholar
  48. 48.
    Bates I (2011) Detrimental effect of fluid resuscitation in the initial management of severely ill children in Africa. Transfus Med 21(5):289–290PubMedCrossRefGoogle Scholar
  49. 49.
    Maitland K, Babiker A, Kiguli S, Molyneux E (2012) The FEAST trial of fluid bolus in African children with severe infection. Lancet 379(9816):613; (author reply − 4)PubMedCrossRefGoogle Scholar
  50. 50.
    Maitland K, Akech S, Russell E (2011) Mortality after fluid bolus in African children with sepsis reply. N Engl J Med 365(14):1351–1353Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.KEMRI-Wellcome Trust ProgrammeKilifiKenya
  2. 2.Department of PaediatricsImperial College LondonLondonUK
  3. 3.Mbale Regional Referral HospitalMbaleUganda

Personalised recommendations